Board of Directors
Executive Director
-
Mr. Wang Chuang (Chairman, chief executive officer and executive director)
View all Details
Mr. Wang Chuang, joined the Group on 18 October 2019 as the Chairman, chief executive officer and executive director of the Company. Mr. Wang has been primarily responsible for overall operation and management, strategic planning and business development.
Mr. Wang was a senior executive of Changzhou Meichen Company Limited* (常州美晨有限公司), Wuxi Shencai Company Limited* (無錫神采有限公司) and Jiangsu Zhenai Company Limited* (江蘇真愛有限公 司) between 2002 and 2008.
He was the chairman of Hong Kong Bomei (China) Company Limited* (香港博美中國分公司) between 2008 and 2019. From 2015 to 2019, he acted as the chief executive officer of Changzhou XingKong Medical Clinic Co., Ltd.* (常州市星空醫療美容門診有限公司) and the chairman of Jiangsu XingKong Health Management Consulting Co., Ltd.* (江蘇星空健康管理諮詢有限公司). He is a committee member of the Organization Committee of the 2017 Boao Forum for Biomedical Sciences *(2017博鰲生物醫學論壇組織委員會) and the founder of Bomei Angel Charity Fund* (博美天使慈善基金). Mr. Wang is the president of the Chamber of Commerce of Changzhou Lishui* (常州溧水商會會長) and the vice president of the China’s National Alliance for Maternal and Child Health Development* (全國婦幼健康促進發展聯盟).
Mr. Wang Chuang was accredited as a grade 1 health management professional and a psychological consultant by the Hubei Provincial Department of Human Resources and Social Security of China and the Ministry of Human Resources and Social Security of China in May 2016 and March 2019.
Non-executive Director
-
Ms. Luo Min
View all Details
Ms. Luo Min, joined the Goup and was appointed as a non-executive Director of the Company on 25 April 2025. Ms. Luo has been appointed as a Professor of the School of Health Policy and Management (南京醫科大學醫政學院) (“SHPM”) and Associate Director of the Department of Health Economics and Management (醫藥經濟與管理系) (“Department of HSM”), of Nanjing Medical University since November 2024. Prior to that, Ms. Luo was the Associate Professor and Head of the Department of Pharmaceutical and Trade Studies of SHPM and Associate Director of the Department of HSM during the period of August 2014 to October 2024, lecturer of SHPM during August 2007 to July 2014, and teaching assistant of SHPM during July 2004 to July 2007. Ms. Luo graduated from Nanjing Audit University (formerly known as Nanjing Audit Institute) with a Bachelor's Degree in Economics from the Department of Finance in 2001, a Master's Degree in Economics from the Department of Finance from Nanjing University in 2004 and a Doctorate Degree in Management from the Department of Accounting from Nanjing University in 2012. She is also a non-practising member of the Chinese Institute of Certified Public Accountants from 2005, and has been appointed as a council member of the 10th Council of Jiangsu Health Economics Society (江蘇省衛生經濟學會第十屆理事會理事) since 2003.
Independent Non-executive Directors
-
Dr. Liu Ming
View all Details
Dr. Liu Ming, joined the Group and was appointed as an independent non-executive Director on 30 December 2021. Dr. Liu graduated from the West China School of Medicine, West China Hospital of Sichuan University in 1991 with a Doctor of Medicine degree. He served in the Department of Otorhinolaryngology, Shenzhen People’s Hospital (Level A) (the “Hospital”) from 1991 to 2016 and served as the head of the Department of Otorhinolaryngology of the Hospital since 1998. He has been served as Deputy Director of the Hospital since 2006. He is currently a special expert of the Hospital in the Department of Otolaryngology. He has more than 25 years of medical clinical and hospital management experience.
Dr. Liu has been serving as executive director and a manager of Shenzhen Jianda Information Technology Limited since 2018, which is mainly engaged in the development and application of sleep breathing monitoring products. Dr. Liu has previously served as a general manager of a subsidiary of the Company since May 2018 and resigned from that position in August 2019.
Dr. Liu holds several community positions including the Standing Director of the Seventh Committee of the Shenzhen Medical Association, the Standing Committee member of the China International Association for the Promotion of Health Care, and the Standing Committee member of the Sleep Medicine Branch of the Guangdong Association of Rehabilitation Medicine.
-
Ms. Huo Chunyu
View all Details
Ms. Huo Chunyu, joined the Group and was appointed as an independent non-executive Director of the Company on 30 January 2020. Ms. Huo obtained a bachelor degree from Hebei University of Economics and Business (河北經貿大學). She has over 20 years of commercial and professional experience with companies including the Industrial and Commercial Bank of China Hebei Branch (中國工商銀行河北省分行), Shijiazhuang Haowei Optoelectronic Thin Film Technology Co., Ltd (石家莊豪 威光電子薄膜技術有限公司) and Hebei Youyuan Certified Public Accountants (河北有源會計師事務所). Since September 2012, she has been a Partner of Ruihua Certified Public Accountants (瑞華會計師事務所).
-
Mr. Leung Man Fai
View all Details
Mr. Leung Man Fai, joined the Group and was appointed as an independent non-executive Director on 30 December 2021. Mr. Leung graduated from Manchester Polytechnic in the United Kingdom with a degree of Bachelor of Arts in Accounting and Finance awarded by the Council for National Academic Awards of the United Kingdom in July 1988. He also obtained a degree of Master of Commerce in Accounting from the University of New South Wales in May 1990.
Mr. Leung has been a member of the HKICPA since June 1991 and has approximately 30 years of working experience in accounting, corporate finance and corporate management.
Mr. Leung is a company secretary of MediNet Group Limited (stock code: 8161), a company listed on the GEM Board of the Stock Exchange since November 2015 and he was a company secretary of Creative Enterprise Holdings Limited (stock code: 3992) from May 2018 to September 2021, which has been delisted from the Stock Exchange from October 2021. Mr. Leung has been an independent non-executive Director of Vital Innovations Holdings Limited (stock code: 6133), a company listed on the Main Board of the Stock Exchange since 30 December 2020.
Senior Management
-
Mr. Yan Shibin (Chief Financial Officer)
View all Details
Mr. Yan Shibin, joined the Goup and was appointed as a Chief Financial Officer of the Company on 25 April 2025. Mr. Yan has extensive experience in finance. He graduated from Zhongnan University of Economics and Law (中南財經政法大學) majoring in finance (investment) (金融學(投資方向)) and obtained a bachelor’s degree in economics in 2000. He served as finance controller of Sichuan Jianzhong Kanghua Hospital Management Co., Ltd. (四川健中康華醫院管理有限公司) during the period of November 2024 to April 2025, chief financial officer of Beijing Aiqihang Network Technology Co., Ltd. (北京愛啟航網絡科技有限公司) during the period of April 2022 to October 2024, chief financial officer of Beijing Qihang Longtu Education Technology Co., Ltd. (北京啟航龍圖教育科技有限公司) during the period of January 2021 to March 2022, vice president of finance of Huatai Motor Group Co., Ltd. (華泰汽車集團有限公司) during the period of May 2016 to December 2020, and chief financial officer of Hanneng New Materials Technology Co., Ltd. (漢能新材料科技有限公司) during the period of August 2013 to April 2016. He has also been admitted as a certified internal auditor of the Institute of Internal Auditors since 1 November 2003, a non-practising member of the Chinese Institute of Certified Public Accountants since 9 December 2014, and an international affiliate of the Hong Kong Institute of Certified Public Accountants since 1 January 2025.